• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用多目标蒙特卡罗树搜索为激酶同源物设计选择性抑制剂。

Selective Inhibitor Design for Kinase Homologs Using Multiobjective Monte Carlo Tree Search.

机构信息

Graduate School of Medical Life Science, Yokohama City University, Tsurumi-ku, Yokohama230-0045, Japan.

RIKEN Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama230-0045, Japan.

出版信息

J Chem Inf Model. 2022 Nov 28;62(22):5351-5360. doi: 10.1021/acs.jcim.2c00787. Epub 2022 Nov 5.

DOI:10.1021/acs.jcim.2c00787
PMID:36334094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9709912/
Abstract

Designing highly selective molecules for a drug target protein is a challenging task in drug discovery. This task can be regarded as a multiobjective problem that simultaneously satisfies criteria for various objectives, such as selectivity for a target protein, pharmacokinetic endpoints, and drug-like indices. Recent breakthroughs in artificial intelligence have accelerated the development of molecular structure generation methods, and various researchers have applied them to computational drug designs and successfully proposed promising drug candidates. However, designing efficient selective inhibitors with releasing activities against various homologs of a target protein remains a difficult issue. In this study, we developed a structure generator based on reinforcement learning that is capable of simultaneously optimizing multiobjective problems. Our structure generator successfully proposed selective inhibitors for tyrosine kinases while optimizing 18 objectives consisting of inhibitory activities against 9 tyrosine kinases, 3 pharmacokinetics endpoints, and 6 other important properties. These results show that our structure generator and optimization strategy for selective inhibitors will contribute to the further development of practical structure generators for drug designs.

摘要

为药物靶标蛋白设计高选择性的分子是药物发现中的一项具有挑战性的任务。这项任务可以被视为一个多目标问题,需要同时满足多个目标的标准,如对靶蛋白的选择性、药代动力学终点和类药性指数。最近人工智能的突破加速了分子结构生成方法的发展,各种研究人员已经将其应用于计算药物设计,并成功提出了有前途的药物候选物。然而,设计具有针对靶蛋白的各种同源物的释放活性的高效选择性抑制剂仍然是一个难题。在这项研究中,我们开发了一种基于强化学习的结构生成器,该生成器能够同时优化多目标问题。我们的结构生成器成功地提出了针对酪氨酸激酶的选择性抑制剂,同时优化了由 9 种酪氨酸激酶的抑制活性、3 种药代动力学终点和 6 种其他重要性质组成的 18 个目标。这些结果表明,我们的选择性抑制剂的结构生成器和优化策略将有助于进一步开发用于药物设计的实用结构生成器。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/ecd52fd0bb0c/ci2c00787_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/c92b98011dca/ci2c00787_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/e40eb403d111/ci2c00787_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/3e668d21f259/ci2c00787_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/5541b0d748a3/ci2c00787_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/ecd52fd0bb0c/ci2c00787_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/c92b98011dca/ci2c00787_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/e40eb403d111/ci2c00787_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/3e668d21f259/ci2c00787_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/5541b0d748a3/ci2c00787_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9709912/ecd52fd0bb0c/ci2c00787_0006.jpg

相似文献

1
Selective Inhibitor Design for Kinase Homologs Using Multiobjective Monte Carlo Tree Search.使用多目标蒙特卡罗树搜索为激酶同源物设计选择性抑制剂。
J Chem Inf Model. 2022 Nov 28;62(22):5351-5360. doi: 10.1021/acs.jcim.2c00787. Epub 2022 Nov 5.
2
Mothra: Multiobjective Molecular Generation Using Monte Carlo Tree Search. mothra:基于蒙特卡洛树搜索的多目标分子生成
J Chem Inf Model. 2024 Oct 14;64(19):7291-7302. doi: 10.1021/acs.jcim.4c00759. Epub 2024 Sep 25.
3
Structure-Based Molecular Generator Combined with Artificial Intelligence and Docking Simulations.基于结构的分子生成器结合人工智能和对接模拟。
J Chem Inf Model. 2021 Jul 26;61(7):3304-3313. doi: 10.1021/acs.jcim.1c00679. Epub 2021 Jul 9.
4
De novo drug design using multiobjective evolutionary graphs.使用多目标进化图进行从头药物设计。
J Chem Inf Model. 2009 Feb;49(2):295-307. doi: 10.1021/ci800308h.
5
Improving Performance Insensitivity of Large-Scale Multiobjective Optimization via Monte Carlo Tree Search.通过蒙特卡洛树搜索提高大规模多目标优化的性能不敏感性
IEEE Trans Cybern. 2024 Mar;54(3):1816-1827. doi: 10.1109/TCYB.2023.3265652. Epub 2024 Feb 9.
6
VGAE-MCTS: A New Molecular Generative Model Combining the Variational Graph Auto-Encoder and Monte Carlo Tree Search.VGAE-MCTS:一种结合变分图自编码器和蒙特卡罗树搜索的新型分子生成模型。
J Chem Inf Model. 2023 Dec 11;63(23):7392-7400. doi: 10.1021/acs.jcim.3c01220. Epub 2023 Nov 22.
7
De Novo Drug Design Using Transformer-Based Machine Translation and Reinforcement Learning of an Adaptive Monte Carlo Tree Search.基于Transformer的机器翻译和自适应蒙特卡罗树搜索强化学习的从头药物设计
Pharmaceuticals (Basel). 2024 Jan 27;17(2):161. doi: 10.3390/ph17020161.
8
Drug Design of Targeted Chemical Libraries Based on Artificial Intelligence and Pair-Based Multiobjective Optimization.基于人工智能和基于对的多目标优化的靶向化学库药物设计。
J Chem Inf Model. 2020 Oct 26;60(10):4582-4593. doi: 10.1021/acs.jcim.0c00517. Epub 2020 Sep 9.
9
De novo generation of dual-target ligands using adversarial training and reinforcement learning.使用对抗训练和强化学习生成双靶配体。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab333.
10
Computational Approaches for the Design of (Mutant-)Selective Tyrosine Kinase Inhibitors: State-of-the-Art and Future Prospects.(突变体)选择性酪氨酸激酶抑制剂设计的计算方法:现状与未来展望
Curr Top Med Chem. 2020;20(17):1564-1575. doi: 10.2174/1568026620666200502005853.

引用本文的文献

1
Leveraging artificial intelligence and machine learning in kinase inhibitor development: advances, challenges, and future prospects.在激酶抑制剂开发中利用人工智能和机器学习:进展、挑战及未来前景。
RSC Med Chem. 2025 Aug 12. doi: 10.1039/d5md00494b.
2
A Multi-Objective Molecular Generation Method Based on Pareto Algorithm and Monte Carlo Tree Search.一种基于帕累托算法和蒙特卡罗树搜索的多目标分子生成方法。
Adv Sci (Weinh). 2025 Apr 4:e2410640. doi: 10.1002/advs.202410640.
3
Large language models open new way of AI-assisted molecule design for chemists.

本文引用的文献

1
Understanding the evolution of a de novo molecule generator via characteristic functional group monitoring.通过特征官能团监测理解从头分子生成器的演变。
Sci Technol Adv Mater. 2022 Jun 1;23(1):352-360. doi: 10.1080/14686996.2022.2075240. eCollection 2022.
2
An Explainable Multiparameter Optimization Approach for Drug Design against Proteins from the Central Nervous System.一种用于中枢神经系统蛋白的药物设计的可解释多参数优化方法。
J Chem Inf Model. 2022 Jun 13;62(11):2685-2695. doi: 10.1021/acs.jcim.2c00462. Epub 2022 May 17.
3
De novo creation of a naked eye-detectable fluorescent molecule based on quantum chemical computation and machine learning.
大语言模型为化学家开启了人工智能辅助分子设计的新途径。
J Cheminform. 2025 Mar 24;17(1):36. doi: 10.1186/s13321-025-00984-8.
4
A data-driven generative strategy to avoid reward hacking in multi-objective molecular design.一种数据驱动的生成策略,用于避免多目标分子设计中的奖励操纵。
Nat Commun. 2025 Mar 11;16(1):2409. doi: 10.1038/s41467-025-57582-3.
5
Mothra: Multiobjective Molecular Generation Using Monte Carlo Tree Search. mothra:基于蒙特卡洛树搜索的多目标分子生成
J Chem Inf Model. 2024 Oct 14;64(19):7291-7302. doi: 10.1021/acs.jcim.4c00759. Epub 2024 Sep 25.
6
DrugGym: A testbed for the economics of autonomous drug discovery.DrugGym:自主药物研发经济学的试验平台。
bioRxiv. 2024 Jun 2:2024.05.28.596296. doi: 10.1101/2024.05.28.596296.
7
Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening.通过基于配体的虚拟预筛选信息指导的进化优化,简化基于片段的药物发现的计算流程。
J Chem Inf Model. 2024 May 13;64(9):3826-3840. doi: 10.1021/acs.jcim.4c00234. Epub 2024 May 2.
8
AI-driven molecular generation of not-patented pharmaceutical compounds using world open patent data.利用世界公开专利数据,通过人工智能驱动进行非专利药物化合物的分子生成。
J Cheminform. 2023 Dec 13;15(1):120. doi: 10.1186/s13321-023-00791-z.
9
Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery.变革药物化学:人工智能在早期药物发现中的应用。
Pharmaceuticals (Basel). 2023 Sep 6;16(9):1259. doi: 10.3390/ph16091259.
基于量子化学计算和机器学习从头创建一种肉眼可检测的荧光分子。
Sci Adv. 2022 Mar 11;8(10):eabj3906. doi: 10.1126/sciadv.abj3906. Epub 2022 Mar 9.
4
Deep generative models for ligand-based de novo design applied to multi-parametric optimization.用于基于配体的从头设计的深度生成模型在多参数优化中的应用。
J Comput Chem. 2022 Apr 15;43(10):692-703. doi: 10.1002/jcc.26826. Epub 2022 Feb 26.
5
DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology.DrugEx v2:基于帕累托的多目标强化学习在多药理学中从头设计药物分子
J Cheminform. 2021 Nov 12;13(1):85. doi: 10.1186/s13321-021-00561-9.
6
AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings.AutoDock Vina 1.2.0:新的对接方法、扩展的力场及Python绑定
J Chem Inf Model. 2021 Aug 23;61(8):3891-3898. doi: 10.1021/acs.jcim.1c00203. Epub 2021 Jul 19.
7
Developing QSAR Models with Defined Applicability Domains on PPARγ Binding Affinity Using Large Data Sets and Machine Learning Algorithms.利用大数据集和机器学习算法,在明确的适用域内开发针对 PPARγ 结合亲和力的 QSAR 模型。
Environ Sci Technol. 2021 May 18;55(10):6857-6866. doi: 10.1021/acs.est.0c07040. Epub 2021 Apr 29.
8
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.ADMETlab 2.0:一个集成的在线平台,用于准确全面地预测 ADMET 性质。
Nucleic Acids Res. 2021 Jul 2;49(W1):W5-W14. doi: 10.1093/nar/gkab255.
9
DeepGraphMolGen, a multi-objective, computational strategy for generating molecules with desirable properties: a graph convolution and reinforcement learning approach.深度图分子生成,一种用于生成具有理想性质分子的多目标计算策略:一种图卷积和强化学习方法。
J Cheminform. 2020 Sep 4;12(1):53. doi: 10.1186/s13321-020-00454-3.
10
Multiobjective de novo drug design with recurrent neural networks and nondominated sorting.基于循环神经网络和非支配排序的多目标从头药物设计
J Cheminform. 2020 Feb 18;12(1):14. doi: 10.1186/s13321-020-00419-6.